Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody
David Burns(Norwegian Womens Public Health Association), Gail Broder(Infectious Disease Research Institute), Robert De La Grecca(Infectious Disease Research Institute), J.R. Mascola, Maurine D. Miner(Fred Hutch Cancer Center), Srilatha Edupuganti(Emory University), Myron S. Cohen(University of North Carolina at Chapel Hill), Ines Frank, Michal J. Sobieszczyk, Allan C. deCamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nidhi Kochar(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Christian Karg, Erika Rudnicki(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Peter L. Anderson(University of Colorado Denver), Lawrence Corey(Fred Hutch Cancer Center), India Tindale(Infectious Disease Research Institute), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Pedro Gonzáles(Hospital Nacional Dos de Mayo), J. Ledgerwood, Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), P. Andrew(Family Health International 360), the HVTN HPTN study group, John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ernest R. Greene(University of North Carolina at Chapel Hill), M. Anderson, Jorge A. Gallardo-Cartagena(National University of San Marcos), J. Lucas(University of North Carolina at Chapel Hill), Nyaradzo Mgodi(University of Zimbabwe)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k